Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014971 · ClinicalTrials.gov registry record · NA
Telehealth in Lewy Body Dementia
A NA study of Lewy Body Disease and Lewy Body Dementia With Behavioral Disturbance, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT05014971: Recruiting NA study of Lewy Body Disease and Lewy Body Dementia With Behavioral Disturbance, sponsored by University of Florida.
NCT05014971 is a NA study of Lewy Body Disease and Lewy Body Dementia With Behavioral Disturbance that is actively recruiting participants, run by University of Florida. The registered enrollment target is 106 participants, below the 468-participant average among 6 other Lewy Body Disease trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05014971, a NA study of Lewy Body Disease and Lewy Body Dementia With Behavioral Disturbance, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.
Primary Outcome
Feasibility will be determined by completion of at least 75% telehealth visits by the intervention cohort
Conditions Studied
Interventions
- BEHAVIORAL Tele-neurohub
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2022-02-28 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT05014971 shows while recruiting
NCT05014971 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 468-participant average among 6 other Lewy Body Disease trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Lewy Body Disease appearing as the primary indexed condition, and to 1 intervention - of which Tele-neurohub is the first listed.
NCT05014971 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05014971 about?
NCT05014971 is a clinical study titled "Telehealth in Lewy Body Dementia". Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, an...
What is the current status of trial NCT05014971?
This trial is currently recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2022-02-28. Estimated completion is 2026-05-31.
What conditions does trial NCT05014971 study?
This clinical trial studies the following conditions: Lewy Body Disease, Lewy Body Dementia With Behavioral Disturbance, Lewy Body Parkinson Disease.
What interventions are being tested in trial NCT05014971?
The interventions under investigation include: Tele-neurohub (BEHAVIORAL).
Who is sponsoring clinical trial NCT05014971?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05014971 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lewy Body Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
RECRUITING · NA
-
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
ACTIVE NOT RECRUITING · NA
-
Stimulation of Cingulo-opercular Alertness Network
COMPLETED · NA
-
A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research
COMPLETED · NA
-
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
RECRUITING
-
NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI